CAS: 66403-32-5 - [6R-[6α,7β(Z)]]-3-(acetoxymethyl)-7-[[2-(formylamino)thiazol-4-yl](methoxyimino)acetamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
Fórmula:C17H17N5O8S2
InChI:InChI=1S/C17H17N5O8S2/c1-7(24)30-3-8-4-31-15-11(14(26)22(15)12(8)16(27)28)20-13(25)10(21-29-2)9-5-32-17(19-9)18-6-23/h5-6,11,15H,3-4H2,1-2H3,(H,20,25)(H,27,28)(H,18,19,23)/b21-10-/t11-,15-/m1/s1
Chave InChI:InChIKey=QUSLXJHSQSHRFM-QVJRADPESA-N
SMILES:O=CNC1=NC(=CS1)C(=NOC)C(=O)NC2C(=O)N3C(C(=O)O)=C(COC(=O)C)CSC32
- Sinónimos:
- (6R,7R)-3-[(acetyloxy)methyl]-7-{[(2E)-2-[2-(formylamino)-1,3-thiazol-4-yl]-2-(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
- (6R-(6alpha,7beta(Z)))-3-(Acetoxymethyl)-7-((2-(formylamino)thiazol-4-yl)(methoxyimino)acetamido)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid
- 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[(acetyloxy)methyl]-7-[[(2Z)-[2-(formylamino)-4-thiazolyl](methoxyimino)acetyl]amino]-8-oxo-, (6R,7R)-
- 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[(acetyloxy)methyl]-7-[[[2-(formylamino)-4-thiazolyl](methoxyimino)acetyl]amino]-8-oxo-, [6R-[6α,7β(Z)]]-
Marca | Dados do produto | Pureza | Gama de preços | Estimativa de entrega |
---|---|---|---|---|
Cefotaxime EP Impurity C REF: 4Z-C-106005CAS: 66403-32-5 | - - - | A consultar | Qui 21 Nov 24 | |
N-Formyl Cefotaxime REF: TR-F698705CAS: 66403-32-5 | - - - | 2.146,00 € | Qui 02 Jan 25 | |
Cefotaxime sodium impurity C REF: 3D-IC63685CAS: 66403-32-5 | Min. 95% | A consultar | Qui 02 Jan 25 |
Cefotaxime EP Impurity C
Ref: 4Z-C-106005
10mg | A consultar | ||
25mg | A consultar | ||
50mg | A consultar | ||
100mg | A consultar |
N-Formyl Cefotaxime
Produto ControladoRef: TR-F698705
100mg | 2.146,00 € |
Cefotaxime sodium impurity C
Ref: 3D-IC63685
1mg | A consultar | ||
5mg | A consultar | ||
10mg | A consultar |